Cargando…
Generation of a new transgenic mouse model for assessment of tau gene silencing therapies
BACKGROUND: Targeting the expression of genes has emerged as a potentially viable therapeutic approach to human disease. In Alzheimer’s disease, therapies that silence the expression of tau could be a viable strategy to slow disease progression. METHODS: We produced a novel strain of transgenic mice...
Autores principales: | Fromholt, Susan, Reitano, Christian, Brown, Hilda, Lewis, Jada, Borchelt, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011353/ https://www.ncbi.nlm.nih.gov/pubmed/27593210 http://dx.doi.org/10.1186/s13195-016-0202-1 |
Ejemplares similares
-
Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology
por: Pace, Michael C., et al.
Publicado: (2018) -
Analysis of spinal and muscle pathology in transgenic mice overexpressing wild-type and ALS-linked mutant MATR3
por: Moloney, Christina, et al.
Publicado: (2018) -
Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype
por: Moloney, Christina, et al.
Publicado: (2016) -
Retraction Note: Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype
por: Moloney, Christina, et al.
Publicado: (2017) -
Multiple Factors Influence the Incubation Period of ALS Prion-like Transmission in SOD1 Transgenic Mice
por: Ayers, Jacob I., et al.
Publicado: (2023)